Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
American Journal of Hematology|January 8, 2026
Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in FranceGuillaume Moulis, Matthieu Mahévas, Jean-François Viallard, et al.
Medicine|December 27, 2011
IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registryMikael Ebbo, Laurent Daniel, Michel Pavic, et al.
The Lancet. Haematology|December 12, 2018
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational studyNicolas Delanoy, Jean-Marie Michot, Thibault Comont, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 1, 2020
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative StudyAlice Canzian, Nils Venhoff, Maria Letizia Urban, et al.
Blood|October 30, 2024
Long-term follow-up of the STOPAGO studyAdrien Cottu, Stéphanie Guillet, Jean-François Viallard, et al.
Blood|September 2, 2022
Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort studyStéphanie Guillet, Valentine Loustau, Emmanuelle Boutin, et al.
Blood|March 9, 2023
Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter studyStéphanie Guillet, Etienne Crickx, Imane Azzaoui, et al.
The Lancet. Rheumatology|January 23, 2024
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational studyAnne Murarasu, Gaëlle Guettrot-Imbert, Véronique Le Guern, et al.
American Journal of Hematology|July 19, 2025
Cold Agglutinin Syndrome Secondary to Mycoplasma pneumoniae Infection in Adults: Results From a Large French Observational Study (MyCOLD Study)Kevin Chevalier, Matthieu Holub, Romain Palich, et al.
American Journal of Hematology|July 8, 2025
Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell ClonesYoann Zadro, Amélie Lusque, Héloïse Rey, et al.
Pageof 19